Fund Overview of Tata India Pharma & Healthcare Fund Regular-growth
-
₹1,229.4 CrAUM
-
₹30.03NAV
-
2.18%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Tata India Pharma & Healthcare Fund Regular-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 5.05% | NA | 6.12% |
| 6 Months | -2.63% | NA | 12.92% |
| 1 Year | 2.78% | 2.78% | 6.04% |
| 2 Years | 19.25% | 9.20% | 24.93% |
| 3 Years | 83.65% | 22.46% | 25.71% |
| 5 Years | 89.23% | 13.60% | 19.91% |
| 7 Years | 224.03% | 18.29% | NA |
| 10 Years | 214.91% | 12.16% | 12.78% |
Asset Allocation
equities
99.69%other assets or cash equivalents
0.31%Tata India Pharma & Healthcare Fund Regular-growth is one Equity mutual fund offered by Tata Mutual Fund. Launched on 28 Dec 2015, the fund aims Long Term Capital Appreciation. Investment in equity/equity related instruments of the companies in the Pharma & Healthcare sector in India. It manages assets worth ₹1,229.4 crore as on Tue Mar 31, 2026. The expense ratio stands at 2.18%. Fund Manager Manager EducationAbout Tata India Pharma & Healthcare Fund Regular-growth
The portfolio allocation consists of 99.69% in equities, 0.31% in other assets or cash equivalents.Managed by Rajat Srivastava, it has delivered a return of 2.78% in the last year, a total return since inception of 11.22%.
Identifying a suitable best sip in india has an important role in long-term wealth creation.
Key Metrics of Tata India Pharma & Healthcare Fund Regular-growth
-
Standard Deviation16.84%
-
Sharpe Ratio0.86%
-
Alpha-2.93%
-
Beta0.99%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| Mirae Asset Healthcare Fund Direct-growth |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| UTI Healthcare Fund Direct-growth |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
| UTI Healthcare Fund Direct-idcw |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
More funds from Tata Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Tata India Pharma & Healthcare Fund Direct-growth
|
₹1,229 | 5.74% | 5.42% | -1.93% | 4.30% | 24.27% |
|
Tata India Pharma & Healthcare Fund Regular-idcw
|
₹1,229 | 5.61% | 5.05% | -2.63% | 2.78% | 22.46% |
|
Tata India Pharma & Healthcare Fund Direct-idcw
|
₹1,229 | 5.74% | 5.42% | -1.93% | 4.30% | 24.27% |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-growth
|
₹153 | 7.30% | 9.42% | 2.52% | 10.91% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-growth
|
₹153 | 7.36% | 9.58% | 2.83% | 11.59% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-idcw
|
₹153 | 7.30% | 9.42% | 2.52% | 10.91% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-idcw
|
₹153 | 7.36% | 9.58% | 2.83% | 11.59% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹517.71 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹580.66 | 23.59% | 14.77% | 15.46% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹111.80 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹158.92 | 23.59% | 14.77% | 15.46% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹23.19 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹426.36 | 24.04% | 15.16% | 11.90% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹492.05 | 25.34% | 16.38% | 13.14% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.94% | ₹130.03 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.03% | ₹130.01 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.59% | ₹127.09 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.59% | ₹127.09 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 10.34% | ₹127.07 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.66% | ₹125.61 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.31% | ₹115.36 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.75% | ₹103.73 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 7.88% | ₹103.31 Cr |
| Cipla Ltd | Healthcare | 6.92% | ₹90.58 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.78% | ₹88.23 Cr |
| Max Healthcare Institute Ltd | Healthcare | 6.24% | ₹77.31 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.94% | ₹77.29 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.87% | ₹76.99 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.65% | ₹75.70 Cr |
| Abbott India Ltd | Healthcare | 5.98% | ₹74.10 Cr |
| Abbott India Ltd | Healthcare | 5.60% | ₹72.83 Cr |
| Abbott India Ltd | Healthcare | 5.89% | ₹72.44 Cr |
| Abbott India Ltd | Healthcare | 5.48% | ₹71.85 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.83% | ₹71.72 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 5.13% | ₹68.62 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.13% | ₹68.00 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.13% | ₹68.00 Cr |
| Abbott India Ltd | Healthcare | 5.04% | ₹67.51 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.15% | ₹67.37 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.37% | ₹66.59 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 5.39% | ₹66.27 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.96% | ₹65.76 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.96% | ₹65.76 Cr |
| Divi's Laboratories Ltd | Healthcare | 5.01% | ₹65.66 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 5.04% | ₹65.61 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.06% | ₹65.59 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 5.00% | ₹65.04 Cr |
| Lupin Ltd | Healthcare | 4.90% | ₹64.97 Cr |
| Lupin Ltd | Healthcare | 4.90% | ₹64.97 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.85% | ₹64.94 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 5.14% | ₹63.67 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.85% | ₹63.50 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.84% | ₹63.46 Cr |
| Lupin Ltd | Healthcare | 4.88% | ₹63.24 Cr |
| Max Healthcare Institute Ltd | Healthcare | 5.14% | ₹63.20 Cr |
| Cipla Ltd | Healthcare | 4.86% | ₹62.97 Cr |
| Cipla Ltd | Healthcare | 5.10% | ₹62.75 Cr |
| Lupin Ltd | Healthcare | 4.79% | ₹62.70 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.71% | ₹62.44 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.71% | ₹62.44 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.76% | ₹62.35 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.97% | ₹61.62 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.68% | ₹60.68 Cr |
| Healthcare Global Enterprises Ltd | Healthcare | 4.68% | ₹60.63 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.63% | ₹60.00 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.52% | ₹59.95 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.52% | ₹59.95 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 4.58% | ₹59.94 Cr |
| Cipla Ltd | Healthcare | 4.55% | ₹59.16 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.42% | ₹58.61 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.42% | ₹58.61 Cr |
| Cipla Ltd | Healthcare | 4.69% | ₹58.10 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.46% | ₹57.74 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 4.40% | ₹57.52 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.31% | ₹56.45 Cr |
| Cipla Ltd | Healthcare | 4.14% | ₹54.29 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.99% | ₹53.46 Cr |
| Abbott India Ltd | Healthcare | 4.02% | ₹53.31 Cr |
| Abbott India Ltd | Healthcare | 4.02% | ₹53.31 Cr |
| Cipla Ltd | Healthcare | 3.96% | ₹53.00 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.05% | ₹52.95 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 4.25% | ₹52.29 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 4.23% | ₹52.01 Cr |
| Cipla Ltd | Healthcare | 3.92% | ₹51.96 Cr |
| Cipla Ltd | Healthcare | 3.92% | ₹51.96 Cr |
| Max Healthcare Institute Ltd | Healthcare | 3.95% | ₹51.13 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.90% | ₹51.08 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.78% | ₹50.58 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.86% | ₹50.02 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.83% | ₹49.84 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.77% | ₹49.41 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.72% | ₹48.79 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.69% | ₹48.34 Cr |
| Lupin Ltd | Healthcare | 3.57% | ₹47.75 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.56% | ₹47.12 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.56% | ₹47.12 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.75% | ₹46.48 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.52% | ₹46.17 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.45% | ₹46.15 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.48% | ₹45.58 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.36% | ₹44.94 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.35% | ₹44.43 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.35% | ₹44.43 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.40% | ₹44.27 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.57% | ₹43.94 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.30% | ₹43.70 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 3.30% | ₹43.70 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.29% | ₹43.60 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.29% | ₹43.60 Cr |
| Bayer Cropscience Ltd | Materials | 3.33% | ₹43.37 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.30% | ₹43.27 Cr |
| Bayer Cropscience Ltd | Materials | 3.23% | ₹43.24 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.26% | ₹43.19 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.26% | ₹43.19 Cr |
| Bayer Cropscience Ltd | Materials | 3.51% | ₹43.12 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.22% | ₹42.68 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.22% | ₹42.68 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.27% | ₹42.56 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.45% | ₹42.36 Cr |
| Sai Life Sciences Ltd. | Healthcare | 3.25% | ₹42.33 Cr |
| Bayer Cropscience Ltd | Materials | 3.23% | ₹42.31 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.18% | ₹42.10 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.18% | ₹42.10 Cr |
| Mankind Pharma Ltd. | Healthcare | 3.38% | ₹41.84 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.21% | ₹41.71 Cr |
| Wockhardt Ltd | Healthcare | 3.22% | ₹41.67 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.20% | ₹41.52 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.10% | ₹41.52 Cr |
| Bayer Cropscience Ltd | Materials | 3.34% | ₹41.46 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.08% | ₹41.26 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.15% | ₹41.22 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.13% | ₹40.68 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 3.09% | ₹40.41 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.00% | ₹40.13 Cr |
| Lupin Ltd | Healthcare | 3.08% | ₹40.11 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.23% | ₹40.02 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.05% | ₹39.91 Cr |
| Lupin Ltd | Healthcare | 3.04% | ₹39.89 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.04% | ₹39.75 Cr |
| Ajanta Pharma Ltd | Healthcare | 3.03% | ₹39.67 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 3.04% | ₹39.60 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.95% | ₹39.45 Cr |
| Wockhardt Ltd | Healthcare | 3.00% | ₹39.24 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.15% | ₹39.11 Cr |
| Lupin Ltd | Healthcare | 3.18% | ₹39.05 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.98% | ₹38.96 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.17% | ₹38.95 Cr |
| Fdc Ltd | Healthcare | 2.93% | ₹38.77 Cr |
| Fdc Ltd | Healthcare | 2.93% | ₹38.77 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.96% | ₹38.76 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.11% | ₹38.59 Cr |
| Metropolis Healthcare Ltd | Healthcare | 2.98% | ₹38.57 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.97% | ₹38.53 Cr |
| Fortis Healthcare Ltd | Healthcare | 3.10% | ₹38.44 Cr |
| Fdc Ltd | Healthcare | 2.87% | ₹38.42 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.89% | ₹38.29 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.89% | ₹38.29 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.85% | ₹38.09 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.84% | ₹38.08 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.94% | ₹38.08 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.06% | ₹37.97 Cr |
| Abbott India Ltd | Healthcare | 2.90% | ₹37.64 Cr |
| Lupin Ltd | Healthcare | 3.03% | ₹37.51 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.85% | ₹37.37 Cr |
| Metropolis Healthcare Ltd | Healthcare | 3.02% | ₹37.09 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.82% | ₹36.90 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.82% | ₹36.51 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.77% | ₹36.24 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.87% | ₹35.52 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.71% | ₹35.28 Cr |
| Cash/net Current Assets | Unspecified | 2.61% | ₹35.25 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.61% | ₹34.90 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.63% | ₹34.81 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.63% | ₹34.81 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.64% | ₹34.36 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.77% | ₹34.29 Cr |
| Pi Industries Ltd | Materials | 2.64% | ₹34.16 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.69% | ₹33.07 Cr |
| Syngene International Ltd | Healthcare | 2.64% | ₹32.48 Cr |
| Repo | Unspecified | 2.39% | ₹32.01 Cr |
| Syngene International Ltd | Healthcare | 2.42% | ₹31.77 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.58% | ₹31.69 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.55% | ₹31.63 Cr |
| Syngene International Ltd | Healthcare | 2.35% | ₹31.43 Cr |
| Syngene International Ltd | Healthcare | 2.39% | ₹31.15 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.39% | ₹30.94 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.33% | ₹30.87 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.33% | ₹30.87 Cr |
| Syngene International Ltd | Healthcare | 2.46% | ₹30.43 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 2.32% | ₹30.39 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.33% | ₹30.14 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.45% | ₹30.14 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.40% | ₹29.56 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.17% | ₹28.81 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.17% | ₹28.81 Cr |
| Pi Industries Ltd | Materials | 2.17% | ₹28.78 Cr |
| Pi Industries Ltd | Materials | 2.17% | ₹28.78 Cr |
| Fdc Ltd | Healthcare | 2.20% | ₹28.76 Cr |
| Cash/net Current Assets | Unspecified | 2.24% | ₹28.68 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.15% | ₹28.01 Cr |
| Fdc Ltd | Healthcare | 2.14% | ₹27.79 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.11% | ₹27.65 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.09% | ₹27.63 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.09% | ₹27.63 Cr |
| Fdc Ltd | Healthcare | 2.08% | ₹27.32 Cr |
| Aurobindo Pharma Ltd | Healthcare | 2.06% | ₹26.91 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.06% | ₹26.77 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.16% | ₹26.73 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 2.04% | ₹26.66 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.99% | ₹26.63 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.01% | ₹26.57 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.01% | ₹26.57 Cr |
| Sanofi India Ltd | Healthcare | 2.02% | ₹26.45 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 2.02% | ₹26.37 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.14% | ₹26.35 Cr |
| Sanofi India Ltd | Healthcare | 2.12% | ₹26.22 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.00% | ₹25.99 Cr |
| Sanofi India Ltd | Healthcare | 1.99% | ₹25.88 Cr |
| Cash/net Current Assets | Unspecified | 1.98% | ₹25.88 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.08% | ₹25.57 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.90% | ₹25.46 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.04% | ₹25.08 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.91% | ₹24.77 Cr |
| Global Health Ltd | Healthcare | 2.01% | ₹24.66 Cr |
| Fdc Ltd | Healthcare | 1.97% | ₹24.39 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.82% | ₹23.84 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.82% | ₹23.72 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.81% | ₹23.70 Cr |
| Fdc Ltd | Healthcare | 1.82% | ₹23.64 Cr |
| Fortis Healthcare Ltd | Healthcare | 1.76% | ₹23.60 Cr |
| Syngene International Ltd | Healthcare | 1.76% | ₹23.37 Cr |
| Syngene International Ltd | Healthcare | 1.76% | ₹23.37 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.75% | ₹22.99 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.77% | ₹22.93 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.70% | ₹22.77 Cr |
| Fdc Ltd | Healthcare | 1.84% | ₹22.61 Cr |
| Syngene International Ltd | Healthcare | 1.73% | ₹22.39 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.71% | ₹22.13 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.78% | ₹22.03 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.64% | ₹21.98 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.63% | ₹21.66 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 1.63% | ₹21.66 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.63% | ₹21.31 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.71% | ₹21.22 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.61% | ₹21.16 Cr |
| Sanofi India Ltd | Healthcare | 1.70% | ₹20.95 Cr |
| Niva Bupa Health Insurance Company Ltd. | Financial | 1.58% | ₹20.46 Cr |
| Niva Bupa Health Insurance Company Ltd. | Financial | 1.56% | ₹20.38 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.55% | ₹20.17 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.55% | ₹20.08 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.50% | ₹20.04 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.51% | ₹20.02 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.51% | ₹20.02 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.50% | ₹19.85 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.50% | ₹19.85 Cr |
| Cash/net Current Assets | Unspecified | 1.53% | ₹19.85 Cr |
| Global Health Ltd | Healthcare | 1.50% | ₹19.57 Cr |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.55% | ₹19.25 Cr |
| Pi Industries Ltd | Materials | 1.44% | ₹18.84 Cr |
| Neuland Laboratories Ltd | Healthcare | 1.52% | ₹18.80 Cr |
| Wockhardt Ltd | Healthcare | 1.41% | ₹18.74 Cr |
| Wockhardt Ltd | Healthcare | 1.41% | ₹18.74 Cr |
| Syngene International Ltd | Healthcare | 1.42% | ₹18.53 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.41% | ₹18.28 Cr |
| Wockhardt Ltd | Healthcare | 1.35% | ₹18.06 Cr |
| Global Health Ltd | Healthcare | 1.42% | ₹17.55 Cr |
| Corona Remedies Ltd. | 1.40% | ₹17.30 Cr | |
| Vijaya Diagnostic Centre Ltd | Healthcare | 1.41% | ₹17.30 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 1.34% | ₹16.48 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 1.22% | ₹16.34 Cr |
| Corona Remedies Ltd. | 1.24% | ₹16.20 Cr | |
| Cash/net Current Assets | Unspecified | 1.18% | ₹15.42 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.22% | ₹15.16 Cr |
| Global Health Ltd | Healthcare | 1.14% | ₹14.94 Cr |
| Aurobindo Pharma Ltd | Healthcare | 1.20% | ₹14.74 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.12% | ₹14.74 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.08% | ₹13.98 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.07% | ₹13.90 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 1.10% | ₹13.54 Cr |
| Zydus Lifesciences Ltd | Healthcare | 1.03% | ₹13.47 Cr |
| Sai Life Sciences Ltd. | Healthcare | 1.02% | ₹13.40 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.01% | ₹13.28 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.02% | ₹13.26 Cr |
| Repo | Unspecified | 0.98% | ₹12.98 Cr |
| Repo | Unspecified | 0.98% | ₹12.98 Cr |
| Corona Remedies Ltd. | 0.99% | ₹12.93 Cr | |
| Pi Industries Ltd | Materials | 0.91% | ₹12.25 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.89% | ₹11.86 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.89% | ₹11.86 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.89% | ₹11.69 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 0.87% | ₹11.64 Cr |
| Indoco Remedies Ltd | Healthcare | 0.87% | ₹11.43 Cr |
| Akums Drugs And Pharmaceuticals Ltd. | Healthcare | 0.88% | ₹11.36 Cr |
| Hikal Ltd | Healthcare | 0.77% | ₹10.04 Cr |
| Medplus Health Services Ltd | Healthcare | 0.76% | ₹10.00 Cr |
| Hikal Ltd | Healthcare | 0.76% | ₹9.91 Cr |
| Wockhardt Ltd | Healthcare | 0.72% | ₹9.48 Cr |
| Hikal Ltd | Healthcare | 0.71% | ₹9.39 Cr |
| Hikal Ltd | Healthcare | 0.71% | ₹9.39 Cr |
| Cash/net Current Assets | Unspecified | 0.72% | ₹9.27 Cr |
| Corona Remedies Ltd. | 0.75% | ₹9.21 Cr | |
| Medplus Health Services Ltd | Healthcare | 0.69% | ₹9.00 Cr |
| Hikal Ltd | Healthcare | 0.68% | ₹8.93 Cr |
| Hikal Ltd | Healthcare | 0.66% | ₹8.78 Cr |
| Procter & Gamble Health Ltd | Healthcare | 0.70% | ₹8.57 Cr |
| Hikal Ltd | Healthcare | 0.60% | ₹7.75 Cr |
| Pi Industries Ltd | Materials | 0.63% | ₹7.71 Cr |
| Hdfc Life Insurance Co Ltd | Financial | 0.62% | ₹7.68 Cr |
| Repo | Unspecified | 0.58% | ₹7.59 Cr |
| Hikal Ltd | Healthcare | 0.61% | ₹7.58 Cr |
| Cash/net Current Assets | Unspecified | 0.55% | ₹6.85 Cr |
| Cash/net Current Assets | Unspecified | 0.55% | ₹6.85 Cr |
| Tata Chemicals Ltd | Materials | 0.50% | ₹6.20 Cr |
| Pi Industries Ltd | Materials | 0.46% | ₹5.98 Cr |
| Pfizer Ltd | Healthcare | 0.42% | ₹5.53 Cr |
| Pfizer Ltd | Healthcare | 0.42% | ₹5.53 Cr |
| Pfizer Ltd | Healthcare | 0.41% | ₹5.35 Cr |
| Sumitomo Chemical India Ltd | Materials | 0.39% | ₹4.81 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.34% | ₹4.15 Cr |
| Medi Assist Healthcare Services Ltd. | Industrials | 0.27% | ₹3.51 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.26% | ₹3.35 Cr |
| Repo | Unspecified | 0.26% | ₹3.21 Cr |
| Repo | Unspecified | 0.20% | ₹2.61 Cr |
| Repo | Unspecified | 0.19% | ₹2.43 Cr |
| Repo | Unspecified | 0.18% | ₹2.22 Cr |
| Repo | Unspecified | 0.14% | ₹1.82 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 0.08% | ₹1.10 Cr |
| Krsnaa Diagnostics Ltd | Healthcare | 0.08% | ₹1.05 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.07% | ₹0.93 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.07% | ₹0.91 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.07% | ₹0.87 Cr |
| Dr. Agarwal’s Health Care Ltd. | Healthcare | 0.07% | ₹0.82 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.06% | ₹0.75 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.06% | ₹0.75 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.06% | ₹0.74 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.06% | ₹0.73 Cr |
| Jubilant Pharmova Ltd | Healthcare | 0.05% | ₹0.66 Cr |
| Indoco Remedies Ltd | Healthcare | 0.04% | ₹0.57 Cr |
| Cash/net Current Assets | Unspecified | 0.05% | ₹0.54 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.04% | ₹0.49 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.04% | ₹0.47 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.03% | ₹0.45 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.03% | ₹0.45 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.03% | ₹0.40 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.03% | ₹0.39 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.02% | ₹0.28 Cr |
| Laxmi Dental Ltd. | Healthcare | 0.02% | ₹0.27 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.00% | ₹0.04 Cr |
| Ipca Laboratories Ltd | Healthcare | 0.00% | ₹0.04 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹492.05 | 25.34% | 16.38% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹341.86 | 25.34% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹45.41 | 26.23% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹27.35 | 26.23% | 16.38% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹23.19 | 27.21% | 16.24% | - |
| UTI Healthcare Fund Direct-growth |
₹331.99 | 26.44% | 15.34% | - |
| UTI Healthcare Fund Direct-idcw |
₹256.60 | 26.44% | 15.34% | - |
Frequently Asked Questions
Tata India Pharma & Healthcare Fund Regular-growth
What is the current AUM of Tata India Pharma & Healthcare Fund Regular-growth?
As of Tue Mar 31, 2026, Tata India Pharma & Healthcare Fund Regular-growth manages assets worth ₹1,229.4 crore
How has Tata India Pharma & Healthcare Fund Regular-growth performed recently?
- 3 Months: 5.05%
- 6 Months: -2.63%
What is the long-term performance of Tata India Pharma & Healthcare Fund Regular-growth?
- 3 Years CAGR: 22.46%
- 5 Years CAGR: 13.60%
- Since Inception: 11.22%
What is the portfolio composition of Tata India Pharma & Healthcare Fund Regular-growth?
Equity: 99.69%, Others: 0.31%.
Who manages Tata India Pharma & Healthcare Fund Regular-growth?
Tata India Pharma & Healthcare Fund Regular-growth is managed by Rajat Srivastava from Tata Mutual Fund.
What is the market-cap allocation of Tata India Pharma & Healthcare Fund Regular-growth?
Large Cap: 35.94%, Mid Cap: 24.32%, Small Cap: 39.74%.
Which are the top companies Tata India Pharma & Healthcare Fund Regular-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 9.94% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.03% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.59% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 9.59% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 10.34% of the fund's portfolio
Which are the major sectors Tata India Pharma & Healthcare Fund Regular-growth focuses on?
- Healthcare – 846.34% of the fund's portfolio
- Materials – 27.95% of the fund's portfolio
- Unspecified – 17.31% of the fund's portfolio
- Other – 4.38% of the fund's portfolio
- Financial – 3.76% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





